Related Experiment Video
Updated: Mar 31, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome
Jefferson J Doyle1,2, Alexander J Doyle1,3, Nicole K Wilson1
1Howard Hughes Medical Institute and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, United States.
Abstract:
Calcium channel blockers (CCBs) are prescribed to patients with Marfan syndrome for prophylaxis against aortic aneurysm progression, despite limited evidence for their efficacy and safety in the disorder. Unexpectedly, Marfan mice treated with CCBs show accelerated aneurysm expansion, rupture, and premature lethality. This effect is both extracellular signal-regulated kinase (ERK1/2) dependent and angiotensin-II type 1 receptor (AT1R) dependent. We have identified protein kinase C beta (PKCβ) as a critical mediator of this pathway and demonstrate that the PKCβ inhibitor enzastaurin, and the clinically available anti-hypertensive agent hydralazine, both normalize aortic growth in Marfan mice, in association with reduced PKCβ and ERK1/2 activation. Furthermore, patients with Marfan syndrome and other forms of inherited thoracic aortic aneurysm taking CCBs display increased risk of aortic dissection and need for aortic surgery, compared to patients on other antihypertensive agents.
Insights
Calcium channel blockers worsen aortic aneurysms in Marfan syndrome mice by activating specific pathways. Treatments targeting protein kinase C beta (PKCβ) show promise for normalizing aortic growth.
Area of Science:
- Cardiovascular Research
- Genetics and Molecular Biology
- Pharmacology
Background:
- Calcium channel blockers (CCBs) are commonly prescribed for Marfan syndrome to prevent aortic aneurysm progression.
- However, evidence supporting their efficacy and safety in this genetic disorder is limited.
- Marfan syndrome is a heritable connective tissue disorder that affects the aorta.
Purpose of the Study:
- To investigate the unexpected adverse effects of CCBs on aortic aneurysm progression in Marfan syndrome.
- To identify the molecular pathways mediating CCB-induced aortic damage.
- To evaluate potential therapeutic interventions for CCB-associated aortic complications.
Main Methods:
- Utilized a mouse model of Marfan syndrome treated with CCBs.
- Investigated the roles of extracellular signal-regulated kinase (ERK1/2) and angiotensin-II type 1 receptor (AT1R) pathways.
- Identified protein kinase C beta (PKCβ) as a key mediator.
- Tested the efficacy of a PKCβ inhibitor (enzastaurin) and hydralazine in normalizing aortic growth.
- Analyzed clinical data from Marfan syndrome patients regarding CCB use and aortic events.
Main Results:
- Marfan mice treated with CCBs exhibited accelerated aortic aneurysm expansion, rupture, and premature death.
- These adverse effects were dependent on both ERK1/2 and AT1R activation.
- PKCβ was identified as a critical mediator in this detrimental pathway.
- Treatment with enzastaurin or hydralazine normalized aortic growth in Marfan mice.
- These treatments were associated with reduced PKCβ and ERK1/2 activation.
- Clinical data revealed an increased risk of aortic dissection and surgery in Marfan patients taking CCBs compared to other antihypertensives.
Conclusions:
- CCBs can paradoxically accelerate aortic aneurysm progression in Marfan syndrome via PKCβ, ERK1/2, and AT1R pathways.
- Targeting PKCβ with inhibitors like enzastaurin or using agents like hydralazine may offer therapeutic benefits.
- Clinical findings suggest caution in using CCBs for Marfan syndrome patients, highlighting the need for alternative antihypertensive strategies.
Related Concept Videos
Gene-Environment Interactions
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Sex-linked Disorders
Pleiotropy

